For the quarter ending 2026-03-31, ELDN has $146,667K in assets. $46,209K in debts. $6,152K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 6,152 | 22,808 | 3,669 | 5,741 |
| Short-term investments | 104,937 | 110,528 | 89,732 | 101,829 |
| Prepaid expenses and other current assets | 2,485 | 2,352 | 2,900 | 3,834 |
| Total current assets | 113,574 | 135,688 | 96,301 | 111,404 |
| Operating lease asset, net | 530 | 613 | 694 | 773 |
| In-process research and development | 32,386 | 32,386 | 32,386 | 32,386 |
| Other assets | 177 | 322 | 476 | 346 |
| Total assets | 146,667 | 169,009 | 129,857 | 144,909 |
| Accounts payable | 6,585 | 3,627 | 4,627 | 5,831 |
| Current operating lease liabilities | 369 | 358 | 346 | 336 |
| Accrued expenses and other liabilities | 6,504 | 14,359 | 9,323 | 7,552 |
| Total current liabilities | 13,458 | 18,344 | 14,296 | 13,719 |
| Deferred tax liabilities | 2,187 | 2,187 | 2,183 | 2,183 |
| Non-current operating lease liabilities | 186 | 283 | 376 | 467 |
| Warrant liabilities | 30,378 | 11,416 | 21,948 | 22,512 |
| Total liabilities | 46,209 | 32,230 | 38,803 | 38,881 |
| Convertible preferred stock, value-Series XNon Voting Convertible Preferred Stock | 2,151 | 2,151 | 2,151 | 2,151 |
| Convertible preferred stock, value-Series X1Non Voting Convertible Preferred Stock | 53,543 | 53,543 | 53,543 | 53,543 |
| Common stock, 0.001 par value, 300,000,000 shares authorized at march 31, 2026 and december 31, 2025 75,851,722 and 75,430,033 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 76 | 75 | 60 | 60 |
| Additional paid-in capital | 484,988 | 482,189 | 426,047 | 423,619 |
| Accumulated other comprehensive income (loss) | -72 | 24 | 9 | -48 |
| Accumulated deficit | -440,228 | -401,203 | -390,756 | -373,297 |
| Total stockholders equity | 44,764 | 81,085 | 35,360 | 50,334 |
| Total liabilities, convertible preferred stock and stockholders' equity | 146,667 | 169,009 | 129,857 | 144,909 |
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)